Netherlands· NL-f385f38e5b5b
Comirnaty XFG 30 microgram/dosis dispersie voor injectie in een voorgevulde sluit
A covid-19, rna-based vaccine product containing bretovameran, registered in Netherlands by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Covid-19, rna-based vaccine is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Covid-19, rna-based vaccine · ATC J07BN01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BRETOVAMERAN
- Manufacturer
- BioNTech Manufacturing GmbH
- Country
- Netherlands (NL)
- ATC code
- J07BN01
- ATC class
- Covid-19, RNA-based vaccine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/20/1528
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Covid-19, rna-based vaccine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandComirnaty JN.1BioNTech Manufacturing GmbH
- CzechiaCOMIRNATY JN.1BioNTech Manufacturing GmbH, Mainz
- SwedenComirnaty JN.1 (10 doser) 3 mikrogram/dos Koncentrat till injektionsvätska, dispersionBioNTech Manufacturing GmbH
- IrelandCOMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 yearsBioNTech Manufacturing GmbH
- FranceCOMIRNATY JN.1 10 microgrammes/dose, dispersion injectable. Vaccin à ARNm contre la COVID-19BIONTECH MANUFACTURING (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Comirnaty Jn.1
- Liechtenstein · Comirnaty Jn.1
- Norway · Comirnaty Jn.1
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b483dc8e-2f6d-427a-81c1-e9f3ac54e448 GET /v1/drugs/b483dc8e-2f6d-427a-81c1-e9f3ac54e448?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Covid-19, RNA-based vaccine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp137297",
"excipients": [
"((4-HYDROXYBUTYL)AZAANDIYL)BIS(HEXAAN-6,1-DIYL)BIS(2-HEXYLDECANOAAT)",
"1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
"2-[(POLYETHYLEENGLYCOL)-2000]-N,N-DITETRADECYLACETAMIDE",
"CHOLESTEROL",
"SACCHAROSE",
"TROMETAMOL",
"TROMETAMOLHYDROCHLORIDE",
"WATER VOOR INJECTIE"
],
"substances": [
"BRETOVAMERAN"
],
"leaflet_url": null,
"authorised_at": "2020/12/21",
"procedure_number": "EMEA/H/C/005735",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/20/1528",
"additional_monitoring": "Y"
}See everything about covid-19, rna-based vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.